Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research
25 avr. 2024 08h50 HE
|
DataHorizzon Research
Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
25 avr. 2024 08h00 HE
|
BioVie, Inc.
“Bezisterim” has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation ...
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
25 avr. 2024 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Smart Pills Market, Size and Global Forecast 2024-2032, Featuring Key Players Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis and Otsuka Holdings
25 avr. 2024 04h03 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Smart Pills Market, Size, Global Forecast 2024-2032, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
24 avr. 2024 22h11 HE
|
Junshi Biosciences
SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company...
Dr. Scharles Konadu Joins TDDC in Fort Worth
24 avr. 2024 08h40 HE
|
GI Alliance
Fort Worth, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Texas Digestive Disease Consultants is excited to welcome Dr. Scharles Konadu, a multi-talented rising star in the gastroenterology field who...
Antispasmodics Drugs: Global Market Analysis and Forecast 2018-2033 Featuring Daiichi Sankyo Company, Fresenius Kabi, Hikma Pharma, Johnson & Johnson Services, Pfizer, and Other Key Players
24 avr. 2024 04h10 HE
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Antispasmodics Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The antispasmodics drugs market size has...
Behavioral Health Market To Reach USD 372.9 Billion By 2032 | DataHorizzon Research
24 avr. 2024 02h40 HE
|
DataHorizzon Research
Fort Collins, Colorado, April 24, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of mental health disorders boosts the need for behavioral health sciences. The increasing prevalence of...
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
23 avr. 2024 16h05 HE
|
Tactile Systems Technology, Inc.
CEO Dan Reuvers to retire; Healthcare veteran and board director Sheri Dodd appointed as Chief Executive OfficerPreliminary, unaudited total revenue for first quarter of 2024 expected to be...
Global Diabetes Drugs Market to Witness an Upsurge in Growth by 2030, Examines DelveInsight | Key Companies in the Market - Sanofi, AstraZeneca, Pfizer, Johnson & Johnson, Novartis, Merck & Co., Novo Nordisk, Eli Lilly and Company, Biocon
23 avr. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, April 23, 2024 (GLOBE NEWSWIRE) -- Global Diabetes Drugs Market to Witness an Upsurge in Growth by 2030, Examines DelveInsight | Key Companies in the Market - Sanofi, AstraZeneca,...